Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc.

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) shares are trading higher Monday after the company announced it entered into a ...

Cardinal Health's growth faces challenges from tariff risks, regulatory uncertainties, and competitive pressures. Learn more ...

Cardinal Health (NYSE: CAH) announced today the U.S. launch of its multi-parameter, single-patient use monitoring cable and ...

Cardinal Health’s (CAH) robust growth in pharmaceutical distribution and oncology drugs positions it to capitalize on ...

Analysts are intrested in these 5 stocks: ( ($CAH) ), ( ($DG) ), ( ($SNOW) ), ( ($CEG) ) and ( ($CRWD) ). Here is a breakdown of their recent ...

Fintel reports that on June 3, 2025, Wells Fargo upgraded their outlook for Cardinal Health (NYSE:CAH) from Equal-Weight to ...

SAN ANTONIO, June 03, 2025--bioAffinity Technologies' collaboration with Cardinal Health's logistics arm ensures CyPath® Lung ...

Cardinal Health Inc. (NYSE:CAH) announced the US launch of its new Kendall DL Multi System. This multi-parameter, ...

Wells Fargo on Tuesday upgraded medical distributors Cardinal Health (NYSE:CAH) and Cencora (NYSE:COR) to Overweight from Equal Weight, citing a strong industry backdrop as a major reason for both ...

Citius Oncology (NASDAQ:CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals (NASDAQ:CTXR), has entered into a distribution services agreement with Cardinal Health (NYSE:CAH). This ...